Table 6. Cost estimates by mode of delivery.

Outcomes	Uterine Rupture		Failed TOLAC		Successful TOLAC		ERCD/Indicated Repeat*
	Baseline	Range	Baseline	Range	Baseline	Range	Baseline	Range
Maternal
Death	27.9	0-1,000.0	27.9	0-1,000.0	24.1	0-1,000.0	27.41	0-1,000.0
Thromboembolism	19.1	9.6-76.5	18.4	9.2-73.5	13.3	6.7-53.3	16.61	8.3-66.4
Hysterectomy	20.4	10.2-81.5	19.6	9.8-78.6	14.6	7.3-58.4	17.9	8.9-71.5
Operative injury	16.4	8.2-65.6	15.7	7.8-62.6	10.6	5.3-42.5	13.9	6.9-55.6
Wound complication	18.1	9.0-72.3	17.3	8.7-69.4	12.3	6.2-49.2	15.6	7.8-62.3
Endometritis	18.2	9.1-73.0	17.5	8.8-70.0	12.5	6.2-49.9	15.7	7.9-63.0
Well (no adverse outcome)	13.9	6.9-20.8	13.1	6.6-19.7	8.1	4.0-12.1	11.4	5.7-17.0
Infant
Death	52.2	0-1,000.0	52.2	0-1,000.0	52.2	0-1,000.0	52.2	0-1,000.0
CP, acute care at birth	82.4	41.2-329.7	82.4	41.2-329.7	82.4	41.2-329.7	n/a	n/a
CP, ongoing care per yr	23.8	11.9-95.1	23.8	11.9-95.1	23.8	11.9-95.1	n/a	n/a
HIE	40.9	20.4-163.5	40.9	20.4-163.5	40.9	20.4-163.5	40.9	20.4-163.5
Sepsis	8.6	4.3-34.2	8.6	4.3-34.2	8.6	4.3-34.2	8.6	4.3-34.2
RDS	25.9	12.9-103.5	25.5	12.7-101.9	25.5	12.7-101.9	25.5	12.7-101.9
TTN	9.1	4.5-36.3	8.7	4.3-34.6	8.7	4.3-34.6	8.7	4.3-34.6
Acidemia	7.7	3.9-30.9	7.3	3.7-29.3	7.3	3.7-29.3	7.3	3.7-29.3
Well (no adverse outcome)	0.9	0.5-1.4	0.9	0.4-1.3	0.9	0.4-1.3	0.9	0.5-1.3

Currency in dollars ($thousands); ERCD, elective repeat cesarean delivery; TOLAC, trial of labor after a previous cesarean;

CP, cerebral palsy; HIE, hypoxic ischemic encephalopathy; RDS, respiratory distress syndrome; TTN, transient tachypnea of the newborn

^*For maternal outcomes placenta previa and accreta in the indicated repeat groups, $5064 and $8561 in additional costs applied, respectively